You are viewing the site in preview mode
Skip to main content
| |
All
|
Women
|
Men
|
|---|
|
HR (95% CI)
|
p-value
|
HR (95% CI)
|
p-value
|
HR (95% CI)
|
p-value
|
|---|
|
Age
|
1.05 (1.01–1.09)
|
0.01
|
1.05 (1.00–1.11)
|
0.04
|
1.04 (0.99–1.11)
|
0.14
|
|
Body Mass Index
|
1.00 (0.95–1.05)
|
0.86
|
1.00 (0.94–1.07)
|
0.91
|
1.01 (0.91–1.10)
|
0.82
|
|
Total Cholesterol
|
1.00 (0.99–1.01)
|
0.53
|
1.00 (0.99–1.01)
|
0.62
|
1.01 (0.98–1.02)
|
0.52
|
|
High Density Lipoprotein
|
0.99 (0.95–1.02)
|
0.59
|
0.98 (0.94–1.03)
|
0.55
|
0.99 (0.92–1.04)
|
0.84
|
|
Systolic Blood Pressure
|
1.03 (1.01–1.06)
|
0.002
|
1.03 (0.99–1.06)
|
0.08
|
1.04 (1.01–1.07)
|
0.007
|
|
Current Smoker
|
2.18 (0.53–6.09)
|
0.19
|
2.45 (0.39–8.46)
|
0.22
|
1.83 (0.10–9.13)
|
0.59
|
|
Diabetes Mellitus
|
1.3 (0.69–2.48)
|
0.40
|
2.82 (0.85–10.77)
|
0.11
|
0.95 (0.18–4.33)
|
0.52
|
|
Inducible Wall Motion Abnormality
|
3.30 (1.56–6.49)
|
0.003
|
0.88 (0.14–3.02)
|
0.86
|
8.86 (3.28–224.90)
|
< 0.001
|
|
Stress-Induced Perfusion Defect
|
2.79 (1.33–5.82)
|
0.007
|
1.62 (0.55–4.38)
|
0.36
|
5.55 (1.85–18.41)
|
0.003
|
|
Any Ischemia
|
3.13 (1.64–5.93)
|
< 0.001
|
1.63 (0.62–3.89)
|
0.30
|
7.41 (2.69–23.54)
|
< 0.001
|
|
Left Ventricular Ejection Fraction
|
0.99 (0.95–1.03)
|
0.65
|
1.04 (0.97–1.12)
|
0.21
|
0.96 (0.89–1.07)
|
0.06
|
|
Late Gadolinium Enhancement
|
2.41 (0.95–5.34)
|
0.06
|
0.71 (0.04–3.48)
|
0.72
|
4.39 (1.41–13.28)
|
0.01
|
- Results of univariate Cox proportional hazard relationships between different risk factors and cardiovascular events/survival. Overall study population results included and those stratified by gender. Of note, for perfusion defects and late gadolinium enhancement, the study population consisted only of those 222 who received contrast